The safety of beta-blocker use in chronic obstructive pulmonary disease patients with respiratory failure in the intensive care unit

Multidisciplinary Respiratory Medicine

Volumn 9, Issue 1, 2014, Pages

  Kargin, Feyza ^a   Takir, Huriye Berk ^a   Salturk, Cuneyt ^a   Goksenoglu, Nezihe Ciftaslan ^a   Karabay, Can Yucel ^a   Mocin, Ozlem Yazicioglu ^a   Adiguzel, Nalan ^a   Gungor, Gokay ^a   Balci, Merih Kalamanoglu ^a   Yalcinsoy, Murat ^a   Kargin, Ramazan ^b   Karakurt, Zuhal ^a  

^a Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital   (Turkey)

^b Denizer Cad Cevizli Kavsagi   (Turkey)

Author keywords

Acute respiratory failure; Arrhythmia; Beta blockers; COPD; Intensive care unit

Indexed keywords

AMIODARONE; ANTIBIOTIC AGENT; BISOPROLOL; CARVEDILOL; DIGITOXIN; DIGOXIN; DILTIAZEM; FORMOTEROL; HYPERTENSIVE AGENT; IPRATROPIUM BROMIDE; METOPROLOL; PREDNISOLONE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE;

ACUTE RESPIRATORY FAILURE; ADULT; AGED; ANTIBIOTIC THERAPY; APACHE; ARTICLE; ARTIFICIAL VENTILATION; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEMOGRAPHY; DISEASE CONTROL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE; HEART VENTRICLE TACHYCARDIA; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; OUTCOME ASSESSMENT; OXYGEN THERAPY; RETROSPECTIVE STUDY; RICHMOND AGITATION SEDATION SCALE; RISK FACTOR; SEPTIC SHOCK; SUPRAVENTRICULAR TACHYCARDIA; TEACHING HOSPITAL;

EID: 84901932599     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/2049-6958-9-8     Document Type: Article

References (38)

1. Falk JA, Kadiev S, Criner GJ, Scharf SM, Minai OA, Diaz P: Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008, 5:543-548. (Pubitemid 351669184)
2. Shibata Y, Watanabe T, Osaka D, Abe S, Inoue S, Tokairin Y, Igarashi A, Yamauchi K, Kimura T, Kishi H, Aida Y, Nunomiya K, Nemoto T, Sato M, Konta T, Kawata S, Kato T, Kayama T, Kubota I: Impairment of pulmonary function is an independent risk factor for atrial fibrillation: the Takahata study. Int J Med Sci 2011, 8: 514-522.
3. Gunduz H, Talay F, Arinc H, Ozyildirim S, Akdemir R, Yolcu M, Kanat M, Uyan C: Heart rate variability and heart rate turbulence in patients with chronic obstructive pulmonary disease. Cardiol J 2009, 16:553-559.
4. Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE Jr, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO: 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009, 54:2205-2241.
5. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, American College of Cardiology Foundation; American Heart Association: 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009, 53:e1-e90.
6. Andrikopoulos G, Pastromas S, Kartalis A, Toli K, Mantas I, Tzeis S, Kyrpizidis C, Olympios C, Manolis AJ, Foussas S, Kranidis A, Pras A, Pipilis A, Chryssos D, Gotsis A, Trikas A, Richter D, Alexopoulos D, Parthenakis F, Theodorakis G, Konstantinides S, Vardas P: Inadequate heart rate control isassociated with worse quality of life in patients with coronary artery disease and chronic obstructive pulmonary disease. The RYTHMOS study. Hellenic J Cardiol 2012, 53:118-126.
7. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD [updated 2013]. http://www.goldcopd.org.
8. Lammers JW, Folgering HT, van Herwaarden CL: Ventilatory effects of long-term treatment with pindolol and metoprolol in hypertensive patients with chronic obstructive lung disease. Br J Clin Pharmacol 1985, 20:205-210. (Pubitemid 15228370)
9. Van der Woude HJ, Zaagsma J, Postma DS, Winter TH, van Hulst M, Aalbers R: Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers. Chest 2005, 127:818-824. (Pubitemid 40775510)
10. Salpeter S, Ormiston T, Salpeter E: Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005, 4:CD003566.
11. Salpeter SR, Ormiston TM, Salpeter EE, Poole PJ, Cates CJ: Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis. Respir Med 2003, 97:1094-1101. (Pubitemid 37185112)
12. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. (Pubitemid 15250137)
13. Nava S, Hill N: Non-invasive ventilation in acute respiratory failure. Lancet 2009, 374:250-259.
14. Ambrosino N, Vagheggini G: Noninvasive positive pressure ventilation in the acute care setting: where are we? Eur Respir J 2008, 31:874-886.
15. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2001, 2003(29):530-538.
16. Spoelstra-de Man AME, Girbes ARJ: Comment on "Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008" by Dellinger et al. Intensive Care Med 2008, 34:1160-1162.
17. European Heart Rhythm Association, European Association for Cardio- ThoracicSurgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, VanGelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH: Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010, 31:2369-2429.
18. Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW, Stevenson WG, Tomaselli GF, Antman EM, Smith SC Jr, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO Jr, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ, European Society of Cardiology Committee, NASPE-Heart Rhythm Society: ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol 2003, 42:1493-1531.
19. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, ESC Committee for Practice Guidelines (CPG): ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008, 10:933-989.
20. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, StruijkerBoudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Kjeldsen SE, Erdine S, Narkiewicz K, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Cifkova R, Dominiczak A, Fagard R, Heagerty AM, Laurent S, Lindholm LH, Mancia G, Manolis A, Nilsson PM, Redon J, Schmieder RE, Struijker-Boudier HA, Viigimaa M, Filippatos G, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Kiowski W, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Viigimaa M, Waeber B, Williams B, Zamorano JL, The task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology: Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007, 2007(28):1462-1536.
21. Nava S, Karakurt S, Rampulla C, Braschi A, Fanfulla F: Salbutamol delivery during non-invasive mechanical ventilation in patients with chronic obstructive pulmonary disease: a randomized, controlled study. Intensive Care Med 2001, 27:1627-1635. (Pubitemid 33027960)
22. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J: Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532-555. (Pubitemid 47403272)
23. Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O'Neal PV, Keane KA, Tesoro EP, Elswick RK: The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002, 166:1338-1344. (Pubitemid 35292699)
24. Boles JM, Bion J, Connors A, Herridge M, Marsh B, Melot C, Pearl R, Silverman H, Stanchina M, Vieillard-Baron A, Welte T: Weaning from mechanical ventilation. Eur Respir J 2007, 29:1033-1056. (Pubitemid 46722227)
25. Cazzola M, Matera MG: Beta-blockers are safe in patients with chronic obstructive pulmonary disease, but only with caution. Am J Respir Crit Care Med 2008, 178:661-662.
26. Callaerts-Vegh Z, Evans KL, Dudekula N, Cuba D, Knoll BJ, Callaerts PF, Giles H, Shardonofsky FR, Bond RA: Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci U S A 2004, 101:4948-4953. (Pubitemid 38469183)
27. Albouaini K, Andron M, Alahmar A, Egred M: Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions. Int J Chron Obstruct Pulmon Dis 2007, 2:535-540. Review.
28. Salpeter SR, Ormiston TM, Salpeter EE: Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004, 125:2309-2321. (Pubitemid 38796452)
29. Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL: Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005, 128:2099-2107. (Pubitemid 41507547)
30. Fabbri LM, Luppi F, Beghé B, Rabe KF: Complex chronic comorbidities of COPD. Eur Respir J 2008, 31:204-212.
31. Mainguy V, Girard D, Maltais F, Saey D, Milot J, Sénéchal M, Poirier P, Provencher S: Effect of bisoprolol on respiratory function and exercise capacity in chronic obstructive pulmonary disease. Am J Cardiol 2012, 110:258-263.
32. Hawkins NM, Jhund PS, Simpson CR, Petrie MC, Macdonald MR, Dunn FG, Macintyre K, McMurray JJ: Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland. Eur J Heart Fail 2010, 12:17-24.
33. Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS: Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial. J Am Coll Cardiol 2010, 55:1780-1787.
34. Dransfield MT, Rowe SM, Johnson JE, Bailey WC, Gerald LB: Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 2008, 63:301-305. (Pubitemid 351497940)
35. Brooks TW, Creekmore FM, Young DC, Asche CV, Oberg B, Samuelson WM: Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers. Pharmacotherapy 2007, 27:684-690. (Pubitemid 46700960)
36. Stefan MS, Rothberg MB, Priya A, Pekow PS, Au DH, Lindenauer PK: Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension. Thorax 2012, 67:977-984.
37. Confalonieri M, Garuti G, Cattaruzza MS, Osborn JF, Antonelli M, Conti G, Kodric M, Resta O, Marchese S, Gregoretti C, Rossi A, Italian noninvasive positive pressure ventilation (NPPV) study group: A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation. Eur Respir J 2005, 25:348-355. (Pubitemid 40246538)
38. Alaithan AM, Memon JI, Rehmani RS, Qureshi AA, Salam A: Chronic obstructive pulmonary disease: hospital and intensive care unit outcomes in the Kingdom of Saudi Arabia. Int J Chron Obstruct Pulmon Dis 2012, 7:819-823.